Acta Medica Iranica 2010. 48(1):61-66.

A Case-Control Study of Risk Factors for Prostate Cancer in Iran
Mostafa Hosseini, Seyed Ahmad SeyedAlinaghi, Mahmoud Mahmoudi, Willi McFarland


Prostate cancer is a major cause of morbidity and mortality in Iran, yet there are few studies examining risk factors specific to the Iranian context. We conducted a case-control study to explore risk factors for prostate cancer in Mazandaran, Iran from 2005 to 2008. The cases were 137 men with clinicopathologically confirmed prostate cancer. Controls were 137 neighborhood and age match men without prostate cancer by PSA and digit examination. Analysis comprised an exploratory stage to identify potential risk factors, defined as variables associated with case status at the P < 0.20 level in conditional logistic regression. A second stage included all potential risk factors in multiple conditional logistic regression analysis, retaining those associated with prostate cancer at the P < 0.05 level. Potential risk factors for prostate cancer in exploratory analysis included family history of prostate cancer, history of other cancer, prostatitis, alcohol consumption, pipe or hookah smoking, walking to work, duration of occupational physical activity, intensity of occupational physical activity, body mass index, and older age. Multivariate analysis found intensity of occupational physical activity, prostatitis, and older age as independent predictors of increased risk for prostate cancer in this Iranian population. Our study confirms several recognized risk factors for prostate cancer, contributes evidence to the discussions of other hypothesized risk factors, and points to potentially new factors. Findings, along with confirmatory studies, can help guide efforts for early detection, treatment, and prevention for this common malignancy that is set to increase in Iran in future decades.


Prostatic neoplasms; risk factors; case- control studies; protatitis; Iran

Full Text:



Grubb RL 3rd, Kibel AS. Prostate cancer: screening, diagnosis and management in 2007. Mo Med 2007;104(5):408-13; quiz 413-4.

Jang TL, Yossepowitch O, Bianco FJ Jr, Scardino PT. Low risk prostate cancer in men under age 65: the case for definitive treatment. Urol Oncol 2007;25(6):510-4.

Canby-Hagino E, Hernandez J, Brand TC, Troyer DA, Higgins B, Ankerst DP, et al. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL. Urology 2007;70(4):748-52.

Rogers LQ, Courneya KS, Paragi-Gururaja R, Markwell SJ, Imeokparia R. et al. Lifestyle behaviors, obesity, and perceived health among men with and without a diagnosisof prostate cancer: a population-based, cross-sectional study. BMC Public Health 2008;8:23.

Jones RA, Underwood SM, Rivers BM. Reducing prostate cancer morbidity and mortality in African American men: issues and challenges. Clin J Oncol Nurs 2007;11(6):865-72.

Cooperberg MR, Broering JM, Kantoff PW, Carroll PR. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 2007;178(3 Pt 2):S14-9.

Pourmand G, Salem S, Mehrsai A, Lotfi M, Amirzargar MA, Mazdak H, et al. The risk factors of prostate cancer: a multicentric case-control study in Iran. Asian Pac J Cancer Prev 2007;8(3):422-8.

Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S; JPHC Study Group. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 2008;167(1):71-7.

Wagenlehner FM, Elkahwaji JE, Algaba F, Bjerklund- Johansen T, Naber KG, Hartung R, et al. The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU Int 2007;100(4):733-7.

Darlington GA, Kreiger N, Lightfoot N, Purdham J, Sass- Kortsak A. Prostate cancer risk and diet, recreational physical activity and cigarette smoking. Chronic Dis Can 2007;27(4):145-53.

Carpenter WR, Robinson WR, Godley PA. Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer. J Natl Cancer Inst 2008;100(3):158-9.

Roddam AW, Allen NE, Appleby P, Key TJ; Endogenous Hormones and Prostate Cancer Collaborative Group. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J NatlCancer Inst 2008;100(3):158-9.

Sass-Kortsak AM, Purdham JT, Kreiger N, Darlington G, Lightfoot NE. Occupational risk factors for prostate cancer. Am J Ind Med 2007;50(8):568-76.

Krstev S, Baris D, Stewart P, Dosemeci M, Swanson GM, Greenberg RS, et al. Occupational risk factors and prostate cancer in U.S. blacks and whites. Am J Ind Med 1998;34(5):421-30.

Gallus S, Foschi R, Talamini R, Altieri A, Negri E, Franceschi S, et al. Risk factors for prostate cancer in men aged less than 60 years: a case-control study from Italy. Urology 2007;70(6):1121-6.

Goldstraw MA, Besrani D, Amoroso P, Kirby RS. Is obesity a risk factor for prostate cancer? BJU Int 2007;100(4):726-8.

Irani J, Lefebvre O, Murat F, Dahmani L, Doré B. Obesity in relation to prostate cancer risk: comparison with a population having benign prostatic hyperplasia. BJU Int 2003;91(6):482-4.

Andersson SO, Wolk A, Bergström R, Adami HO, Engholm G, Englund A, et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997;89(5):385-9.

Schoonen WM, Salinas CA, Kiemeney LA, Stanford JL. Alcohol consumption and risk of prostate cancer in middleaged men. Int J Cancer 2005;113(1):133-40.

Dennis LK. Meta-analysis for combining relative risks of alcohol consumption and prostate cancer. Prostate 2000;42(1):56-66.

Qin LQ, Xu JY, Wang PY, Tong J, Hoshi K. Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. Asia Pac J Clin Nutr 2007;16(3):467-76.

Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, et al. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 2007;99(15):1200-9.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.